Inactivating mutations in SMARCB1 confer an oncogenic dependency on EZH2 in atypical teratoid rhabdoid tumors (ATRTs), but the underlying mechanism has not been fully elucidated. This evidence concerns the gene SMARCB1 and atypical teratoid rhabdoid tumor.